Development of a Multiomics Assay for Use on OriColTM Sampled Rectal Mucus for Detection of Cancer and Significant Polyps in Symptomatic Patients on the Colorectal Urgent Suspected Cancer Pathway
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
Development of a multiomics assay for use on OriColTM sampled rectal mucus for detection of cancer and significant polyps in symptomatic patients on the Colorectal Urgent Suspected Cancer pathway.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
Healthy Volunteers: f
View:
• Patients 18 years and over
• Patients referred from primary care to the 'urgent suspected cancer' CRC pathway during the study period.
• Patients who provide voluntary written informed consent to participate in the study.
Locations
Other Locations
United Kingdom
Shrewsbury & Telford NHS Foundation Trust
RECRUITING
Telford
Contact Information
Primary
Jon Lacy-Colson, FRCS
jon.lacy-colson@sath.nhs.uk
+44(0)1743261000
Backup
Ian Daniels, FRCS
ian.daniels@originsciences.com
+44(0)1256 750490
Time Frame
Start Date: 2024-11-01
Estimated Completion Date: 2027-04-01
Participants
Target number of participants: 6600
Related Therapeutic Areas
Sponsors
Leads: Origin Sciences
Collaborators: Shrewsbury and Telford Hospitals NHS Trust